Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs H World Group Limited American Depositary Shares (HTHT) Price & Performance

Citius Pharmaceuticals IncTrade
H World Group Limited American Depositary SharesTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs H World Group Limited American Depositary Shares — how do they compare? Citius Pharmaceuticals Inc trades at $0.49 (market cap $13.62M), while H World Group Limited American Depositary Shares trades at $43.58 (market cap $13.25B). The key difference: H World Group Limited American Depositary Shares is far larger — about 972.8× Citius Pharmaceuticals Inc's market cap, and H World Group Limited American Depositary Shares pays a 5.08% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Citius Pharmaceuticals Inc for 16 Days and H World Group Limited American Depositary Shares for 0 Days on average.

CTXRHTHT
Market Cap
$13.62M$13.25B
Volume
132,4381,177,261
Sector
HealthConsumer Cyclical
52-Week High
$1.82$56.06
52-Week Low
$0.48$36.99
Typical Hold Time
16 Days0 Days
Enterprise Value
$3.79M$16.03B
Dividend Yield
—5.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citius Pharmaceuticals Inc

CTXR trades at $0.5082, up 5.72% today, amid a bearish technical trend but with oversold oscillators suggesting potential for a near-term bounce. The company reported its first revenue of $7 million in 2026 from LYMPHIR sales, yet remains deeply unprofitable with a net income margin of -651.27%. Analyst consensus is strongly positive with five buy ratings and a $5.00 price target, highlighting optimism around its oncology drug launch despite significant cash burn from operations.

The outlook hinges on successful commercialization of LYMPHIR to offset steep losses. Investment opportunity lies in the drug's market adoption and analyst bullishness, but risks include sustained negative cash flow, execution challenges, and the stock's high volatility. Shareholder value depends on translating revenue growth into profitability.

H World Group Limited American Depositary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTXR
2% Buy98% Sell
Avg holding period · 16 Days
HTHT
100% Buy0% Sell
Avg holding period · 0 Days

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR →

About H World Group Limited American Depositary Shares

H World Group operates hotels through leased and owned, managed franchise, and franchise models. Its brands include HanTing, JI Hotel, Orange Hotel, and Steigenberger Hotels & Resorts.

Read more on HTHT →